Obama’s appointee to head the FDA is a Big Pharma mega-lobbyist
by: Daniel Barker
NaturalNews.com
January 16, 2016
n his last months in office, President Obama continues to pursue his policy of appointing industry insiders and lobbyists to important posts within the federal government.
A glaring example is his recent nomination of Dr. Robert Califf to become the new head of the FDA when current commissioner Margaret Hamburg steps down in March.
Califf has just received the support of a Senate committee, and is now expected to receive full senate approval of the appointment – despite revelations that he has close ties to the pharmaceutical industry.
Even mainstream media outlets have voiced concerns over the appointment. A number of journalists and observers are questioning the potential impartiality of an appointee who has worked so closely with Big Pharma for so many years.
‘Deep financial and intellectual ties’
The Rest…HERE
